{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:17:41Z","timestamp":1783034261803,"version":"3.54.6"},"reference-count":144,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaip.2018.11.026","type":"journal-article","created":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T08:59:19Z","timestamp":1551603559000},"page":"788-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Skin as a Window into Primary Immune Deficiency Diseases: Atopic Dermatitis and Chronic Mucocutaneous Candidiasis"],"prefix":"10.1016","volume":"7","author":[{"given":"Heather","family":"Lehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.11.026_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1525-1470.2011.01409.x","article-title":"Skin manifestations in primary immunodeficient children","volume":"28","author":"Al-Herz","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1525-1470.2000.01721.x","article-title":"Cutaneous markers of primary immunodeficiency diseases in children","volume":"17","author":"Berron-Ruiz","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib4","first-page":"121","article-title":"Cutaneous manifestations of primary immunodeficiency diseases in children","volume":"5","author":"Moin","year":"2006","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.11.026_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","article-title":"Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood","volume":"103","author":"Williams","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2010.251","article-title":"Eczema prevalence in the United States: data from the 2003 National Survey of Children\u2019s Health","volume":"131","author":"Shaw","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib7","doi-asserted-by":"crossref","first-page":"e39803","DOI":"10.1371\/journal.pone.0039803","article-title":"Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies","volume":"7","author":"Deckers","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jaip.2018.11.026_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.aller.2013.02.004","article-title":"Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis","volume":"42","author":"Aghamohammadi","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2018.11.026_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job\u2019s syndrome. Recurrent, \u201ccold\u201d, staphylococcal abscesses","volume":"1","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2018.11.026_bib10","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2006.12.666","article-title":"Causes of death in hyper-IgE syndrome","volume":"119","author":"Freeman","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib11","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2018.11.026_bib13","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2018.11.026_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clim.2008.08.002","article-title":"Reduced memory B cells in patients with hyper IgE syndrome","volume":"129","author":"Speckmann","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib16","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2008.03.002","article-title":"Cytokine signaling modules in inflammatory responses","volume":"28","author":"O'Shea","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2018.11.026_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaci.2013.05.029","article-title":"Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function","volume":"132","author":"Ives","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A\u00a0critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2018.11.026_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.20091706","article-title":"B\u00a0cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans","volume":"207","author":"Avery","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jaad.2010.09.714","article-title":"Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis","volume":"65","author":"Olaiwan","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anai.2009.11.015","article-title":"Skin-deep clues to a complex disease","volume":"104","author":"Cho","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archderm.140.9.1119","article-title":"Dermatitis and the newborn rash of hyper-IgE syndrome","volume":"140","author":"Eberting","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.20082767","article-title":"Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome","volume":"206","author":"Minegishi","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib25","first-page":"e23435","article-title":"STAT3 and the hyper-IgE syndrome: clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties","volume":"2","author":"Mogensen","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.jaip.2018.11.026_bib26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2009.03.030","article-title":"TH17 cells and regulatory T cells in primary immunodeficiency diseases","volume":"123","author":"Ochs","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(74)91942-4","article-title":"Defect in neutrophil granulocyte chemotaxis in Job\u2019s syndrome of recurrent \u201ccold\u201d staphylococcal abscesses","volume":"2","author":"Hill","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2018.11.026_bib28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-82-6-766","article-title":"Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E","volume":"82","author":"Van Scoy","year":"1975","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2018.11.026_bib30","doi-asserted-by":"crossref","first-page":"e1271","DOI":"10.1542\/peds.2006-0311","article-title":"Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome","volume":"118","author":"Freeman","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2018.11.026_bib31","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","article-title":"Autosomal dominant hyper-IgE syndrome in the USIDNET Registry","volume":"6","author":"Gernez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.11.026_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2009.07.007","article-title":"Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome","volume":"124","author":"Melia","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections\u2014an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10875-011-9515-9","article-title":"Coronary artery abnormalities in hyper-IgE syndrome","volume":"31","author":"Freeman","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archdermatol.2011.262","article-title":"Cutaneous manifestations of DOCK8 deficiency syndrome","volume":"148","author":"Chu","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib36","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2013.08.045","article-title":"Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation","volume":"132","author":"Siegel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","article-title":"Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome","volume":"124","author":"Engelhardt","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clim.2014.04.005","article-title":"Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency","volume":"153","author":"Al-Zahrani","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clim.2014.03.008","article-title":"Expansion of CCR4+ activated T cells is associated with memory B cell reduction in DOCK8-deficient patients","volume":"152","author":"Caracciolo","year":"2014","journal-title":"Clini Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2010.09743.x","article-title":"Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review","volume":"163","author":"Bath-Hextall","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/08880018.2012.714844","article-title":"Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen","volume":"29","author":"Boztug","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2018.11.026_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clim.2014.03.006","article-title":"Haploidentical stem cell transplantation in DOCK8 deficiency\u2014successful control of pre-existing severe viremia with a TCRass\/CD19-depleted graft and antiviral treatment","volume":"152","author":"Ghosh","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaip.2018.11.026_bib44","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2014.02.025","article-title":"Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels","volume":"133","author":"Sassi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib45","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2012.00211","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity","volume":"3","author":"Barzaghi","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaad.2005.08.047","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature","volume":"55","author":"McGinness","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2018.11.026_bib48","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s10875-008-9176-5","article-title":"Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED","volume":"28","author":"Moraes-Vasconcelos","year":"2008","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib49","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaci.2008.10.023","article-title":"Primary immune deficiencies with aberrant IgE production","volume":"122","author":"Ozcan","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib50","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2007.02.044","article-title":"Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene","volume":"132","author":"Torgerson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2018.11.026_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaut.2010.06.017","article-title":"The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies","volume":"35","author":"Tsuda","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2018.11.026_bib52","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jaci.2007.08.044","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells","volume":"120","author":"Torgerson","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis","volume":"15","author":"Gambineri","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib54","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib55","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1189\/jlb.2A0215-050RR","article-title":"WASp-dependent actin cytoskeleton stability at the dendritic cell immunological synapse is required for extensive, functional T cell contacts","volume":"99","author":"Malinova","year":"2016","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2018.11.026_bib56","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1182\/blood.V98.4.1142","article-title":"Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation","volume":"98","author":"Burns","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.11.026_bib57","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood-2009-09-239087","article-title":"X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options","volume":"115","author":"Albert","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.11.026_bib58","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","article-title":"Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.11.026_bib59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/85886","article-title":"Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia","volume":"27","author":"Devriendt","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2018.11.026_bib60","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A\u00a0multi-institutional survey of the Wiskott-Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2018.11.026_bib61","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood-2003-07-2621","article-title":"Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect","volume":"104","author":"Gismondi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.11.026_bib62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI29539","article-title":"Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis","volume":"117","author":"Humblet-Baron","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2018.11.026_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.20061338","article-title":"The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells","volume":"204","author":"Maillard","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib64","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI106731","article-title":"Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism","volume":"50","author":"Blaese","year":"1971","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2018.11.026_bib65","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1182\/blood.V82.10.2961.2961","article-title":"Splenectomy and\/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases","volume":"82","author":"Mullen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.11.026_bib66","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpeds.2011.02.039","article-title":"Practical guidelines for managing patients with 22q11.2 deletion syndrome","volume":"159","author":"Bassett","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2018.11.026_bib67","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.anai.2017.02.025","article-title":"A\u00a0case of atypical, complete DiGeorge syndrome without 22q11 mutation","volume":"118","author":"Stone","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0560.2007.00816.x","article-title":"The cutaneous manifestations of atypical complete DiGeorge syndrome: a histopathologic and immunohistochemical study","volume":"35","author":"Selim","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaip.2018.11.026_bib69","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1442-200X.2012.03722.x","article-title":"Clinical and immunophenotypic features of atypical complete DiGeorge syndrome","volume":"55","author":"Vu","year":"2013","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaip.2018.11.026_bib70","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI115139","article-title":"Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn\u2019s syndrome)","volume":"87","author":"de Saint-Basile","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2018.11.026_bib71","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jaip.2018.11.026_bib72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199002013220507","article-title":"Transfusion-associated graft-versus-host disease","volume":"323","author":"Anderson","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4049\/jimmunol.138.2.423","article-title":"Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation","volume":"138","author":"Le Deist","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2018.11.026_bib75","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/adc.79.2.186","article-title":"Neonatal erythroderma: differential diagnosis and management of the \u201cred baby\u201d","volume":"79","author":"Hoeger","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2018.11.026_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-4632.2004.01975.x","article-title":"Erythroderma\/exfoliative dermatitis: a synopsis","volume":"43","author":"Sehgal","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib77","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1515\/hsz-2014-0137","article-title":"Netherton syndrome: defective kallikrein inhibition in the skin leads to skin inflammation and allergy","volume":"395","author":"Furio","year":"2014","journal-title":"Biol Chem"},{"key":"10.1016\/j.jaip.2018.11.026_bib78","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaci.2014.07.008","article-title":"IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome","volume":"134","author":"Hannula-Jouppi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pde.12220","article-title":"Netherton syndrome associated with growth hormone deficiency","volume":"31","author":"Aydin","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib80","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1684\/ejd.2016.2761","article-title":"Exocrine pancreatic insufficiency in a child with Netherton syndrome","volume":"26","author":"Machet","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib81","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1021\/jm500988d","article-title":"Toward the first class of suicide inhibitors of kallikreins involved in skin diseases","volume":"58","author":"Tan","year":"2015","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jaip.2018.11.026_bib82","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/humc.2013.195","article-title":"Phase I study protocol for ex\u00a0vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome","volume":"24","author":"Di","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.jaip.2018.11.026_bib83","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/302547","article-title":"Genetic linkage of hyper-IgE syndrome to chromosome 4","volume":"65","author":"Grimbacher","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaip.2018.11.026_bib84","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jaci.2010.06.029","article-title":"Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis","volume":"126","author":"Schimke","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib85","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaci.2014.12.1945","article-title":"The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency","volume":"136","author":"Engelhardt","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib86","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.03.034","article-title":"TH17 deficiency in human disease","volume":"129","author":"McDonald","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A\u00a0distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib88","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","article-title":"Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation","volume":"139","author":"Weinacht","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib90","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.1401467","article-title":"Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody","volume":"193","author":"Yamazaki","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib91","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib92","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib93","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10875-012-9659-2","article-title":"A\u00a0novel STAT1 mutation associated with disseminated mycobacterial disease","volume":"32","author":"Sampaio","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib94","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0140-6736(12)60365-1","article-title":"Herpes in STAT1 gain-of-function mutation [corrected]","volume":"379","author":"Toth","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2018.11.026_bib95","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib96","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1","volume":"36","author":"Depner","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib97","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2014.05.044","article-title":"Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding","volume":"134","author":"Frans","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2015.05.183","article-title":"Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation","volume":"196","author":"Tanimura","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaip.2018.11.026_bib99","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MOP.0000000000000028","article-title":"Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis","volume":"25","author":"Kisand","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaip.2018.11.026_bib100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fmicb.2015.00429","article-title":"Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?","volume":"6","author":"Thakur","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaip.2018.11.026_bib101","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","article-title":"Human dectin-1 deficiency and mucocutaneous fungal infections","volume":"361","author":"Ferwerda","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib102","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJMc0911468","article-title":"Dectin-1 deficiency and mucocutaneous fungal infections","volume":"362","author":"Marodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib103","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jaci.2011.12.966","article-title":"Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects","volume":"129","author":"Engelhardt","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib104","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2012-08-450551","article-title":"Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency","volume":"121","author":"Drewniak","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.11.026_bib105","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A\u00a0homozygous CARD9 mutation in a family with susceptibility to fungal infections","volume":"361","author":"Glocker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib106","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1208487","article-title":"Deep dermatophytosis and inherited CARD9 deficiency","volume":"369","author":"Lanternier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib107","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20090067","article-title":"The adaptor molecule CARD9 is essential for tuberculosis control","volume":"207","author":"Dorhoi","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib108","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ni1426","article-title":"The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens","volume":"8","author":"Hsu","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaip.2018.11.026_bib110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.20141065","article-title":"Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis","volume":"212","author":"Ling","year":"2015","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib111","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","article-title":"An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis","volume":"39","author":"Boisson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2018.11.026_bib112","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.aaa4282","article-title":"IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations","volume":"349","author":"Okada","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaip.2018.11.026_bib113","first-page":"328","article-title":"Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half years","volume":"38","author":"Thorpe","year":"1929","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaip.2018.11.026_bib114","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jcem-6-7-493","article-title":"Chronic idiopathic hypoparathyroidism with superimposed Addison\u2019s disease in a child","volume":"6","author":"Leonard","year":"1946","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.jaip.2018.11.026_bib115","doi-asserted-by":"crossref","first-page":"e88782","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2018.11.026_bib116","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","article-title":"An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains","volume":"17","author":"Finnish-German","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2018.11.026_bib117","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2018.11.026_bib118","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1159407","article-title":"Deletional tolerance mediated by extrathymic Aire-expressing cells","volume":"321","author":"Gardner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jaip.2018.11.026_bib119","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri1436","article-title":"Self-representation in the thymus: an extended view","volume":"4","author":"Kyewski","year":"2004","journal-title":"Nature Rev Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib120","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/jc.2005-2611","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"91","author":"Perheentupa","year":"2006","journal-title":"The J Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.jaip.2018.11.026_bib121","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2005.09.022","article-title":"Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity","volume":"25","author":"Peterson","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2018.11.026_bib122","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib123","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib124","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/eji.201041253","article-title":"Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications","volume":"41","author":"Kisand","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.oraloncology.2006.07.005","article-title":"Oral and oesophageal squamous cell carcinoma\u2014a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I)","volume":"43","author":"Rautemaa","year":"2007","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaip.2018.11.026_bib126","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-2133.2006.07166.x","article-title":"Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome","volume":"154","author":"Collins","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib127","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","article-title":"Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I","volume":"265","author":"Husebye","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options\u2014a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib129","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/cmi.2017.9","article-title":"DOCK8 regulates signal transduction events to control immunity","volume":"14","author":"Kearney","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib130","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2016.07.016","article-title":"Dedicator of cytokinesis 8-deficient CD4(+) T cells are biased to a TH2 effector fate at the expense of TH1 and TH17 cells","volume":"139","author":"Tangye","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib131","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib132","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/cid\/ciu215","article-title":"CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy","volume":"59","author":"Gavino","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2018.11.026_bib133","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/jamadermatol.2014.2154","article-title":"Posaconazole treatment of extensive skin and nail dermatophytosis due to autosomal recessive deficiency of CARD9","volume":"151","author":"Jachiet","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2018.11.026_bib134","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20071119","article-title":"GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival","volume":"205","author":"Sonderegger","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib135","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.11.026_bib136","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1574-6976.2010.00232.x","article-title":"Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy","volume":"34","author":"van de Veerdonk","year":"2010","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jaip.2018.11.026_bib137","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10875-013-9947-5","article-title":"A\u00a01-year-old girl with a gain-of-function STAT1 mutation treated with hematopoietic stem cell transplantation","volume":"33","author":"Aldave","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib138","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib139","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O'Shea","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaip.2018.11.026_bib140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib141","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/ciw020","article-title":"Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"62","author":"Mossner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2018.11.026_bib142","doi-asserted-by":"crossref","first-page":"ofx202","DOI":"10.1093\/ofid\/ofx202","article-title":"Risks of ruxolitinib in STAT1 gain-of-function-associated severe fungal disease","volume":"4","author":"Zimmerman","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaip.2018.11.026_bib143","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function STAT1 or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.11.026_bib144","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13192","article-title":"HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis","volume":"194","author":"Rosler","year":"2018","journal-title":"Clin Exp Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818307542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818307542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:18:17Z","timestamp":1761974297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818307542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2213219818307542"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.11.026","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Skin as a Window into Primary Immune Deficiency Diseases: Atopic Dermatitis and Chronic Mucocutaneous Candidiasis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}